These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

57 related articles for article (PubMed ID: 22096892)

  • 1. [Entry mechanisms of HCV].
    Tani H; Matsuura Y
    Nihon Rinsho; 2011 May; 69 Suppl 4():47-51. PubMed ID: 22096892
    [No Abstract]   [Full Text] [Related]  

  • 2. Claudin-1 and its potential role in HCV entry: another piece of the puzzle.
    Hamilton JP; Thuluvath PJ
    J Clin Gastroenterol; 2008 Jan; 42(1):3-4. PubMed ID: 18097281
    [No Abstract]   [Full Text] [Related]  

  • 3. Hepatitis C virus entry: an intriguing challenge for drug discovery.
    Meanwell NA
    Curr Opin Investig Drugs; 2006 Aug; 7(8):727-32. PubMed ID: 16955684
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Lipoprotein lipase mediates hepatitis C virus (HCV) cell entry and inhibits HCV infection.
    Andréo U; Maillard P; Kalinina O; Walic M; Meurs E; Martinot M; Marcellin P; Budkowska A
    Cell Microbiol; 2007 Oct; 9(10):2445-56. PubMed ID: 17517063
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Viral dynamics in hepatitis C.
    Kershenobich D; Henonin CH
    Isr Med Assoc J; 2001 May; 3(5):360-3. PubMed ID: 11411202
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Entry of pseudotyped hepatitis C virus into primary human hepatocytes depends on the scavenger class B type I receptor.
    Régeard M; Trotard M; Lepère C; Gripon P; Le Seyec J
    J Viral Hepat; 2008 Dec; 15(12):865-70. PubMed ID: 19087225
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Hepatitis C virus infection and morphologic study in B lymphocytes of patient with hepatitis C.
    Yao P; Chan L; Hu X; Chen P; Hu D
    Zhonghua Gan Zang Bing Za Zhi; 2001 Feb; 9(1):31-3. PubMed ID: 11242132
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [HCV virus: virological aspects and laboratory diagnosis].
    González J; Fay F
    Acta Gastroenterol Latinoam; 2006 Jun; 36 Suppl 1():S18-20; discussion S74-82. PubMed ID: 16862848
    [No Abstract]   [Full Text] [Related]  

  • 9. Treatment of HCV recurrence: do the pretransplantation rules apply?
    Burton JR; Rosen HR
    Liver Transpl; 2006 Jul; 12(7):1044-8. PubMed ID: 16799952
    [No Abstract]   [Full Text] [Related]  

  • 10. [Measurement of strand-specific hepatic HCV-RNA quantities of patients with hepatitis C virus infection].
    Hige S
    Nihon Rinsho; 2004 Jul; 62 Suppl 7(Pt 1):417-21. PubMed ID: 15359834
    [No Abstract]   [Full Text] [Related]  

  • 11. Virology and pathogenesis of hepatitis C virus recurrence.
    Ramírez S; Pérez-Del-Pulgar S; Forns X
    Liver Transpl; 2008 Oct; 14 Suppl 2():S27-35. PubMed ID: 18825723
    [TBL] [Abstract][Full Text] [Related]  

  • 12. In vitro replication models for the hepatitis C virus.
    Sheehy P; Mullan B; Moreau I; Kenny-Walsh E; Shanahan F; Scallan M; Fanning LJ
    J Viral Hepat; 2007 Jan; 14(1):2-10. PubMed ID: 17212638
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Hepatitis C virus production requires apolipoprotein A-I and affects its association with nascent low-density lipoproteins.
    Mancone C; Steindler C; Santangelo L; Simonte G; Vlassi C; Longo MA; D'Offizi G; Di Giacomo C; Pucillo LP; Amicone L; Tripodi M; Alonzi T
    Gut; 2011 Mar; 60(3):378-86. PubMed ID: 20940285
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Non-human primate surrogate model of hepatitis C virus infection.
    Akari H; Iwasaki Y; Yoshida T; Iijima S
    Microbiol Immunol; 2009 Jan; 53(1):53-7. PubMed ID: 19161559
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Convert hepatitis C virus into a non-enveloped virus like hepatitis A, by targeting its envelope rather than the RNA.
    Helmy A
    Med Hypotheses; 2006; 66(4):847-50. PubMed ID: 16229965
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Molecular biology of hepatitis C infection.
    Drazan KE
    Liver Transpl; 2000 Jul; 6(4):396-406. PubMed ID: 10915159
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Additive effect of ethanol and HCV subgenomic replicon expression on COX-2 protein levels and activity.
    Trujillo-Murillo K; Alvarez-Martínez O; Garza-Rodríguez L; Martínez-Rodríguez H; Bosques-Padilla F; Ramos-Jiménez J; Barrera-Saldaña H; Rincón-Sánchez AR; Rivas-Estilla AM
    J Viral Hepat; 2007 Sep; 14(9):608-17. PubMed ID: 17697012
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Hepatitis C virus particles and lipoprotein metabolism.
    André P; Perlemuter G; Budkowska A; Bréchot C; Lotteau V
    Semin Liver Dis; 2005 Feb; 25(1):93-104. PubMed ID: 15732001
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Hepatitis A virus infection suppresses hepatitis C virus replication and may lead to clearance of HCV.
    Deterding K; Tegtmeyer B; Cornberg M; Hadem J; Potthoff A; Böker KH; Tillmann HL; Manns MP; Wedemeyer H
    J Hepatol; 2006 Dec; 45(6):770-8. PubMed ID: 17034895
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Assembly of infectious hepatitis C virus particles.
    Bartenschlager R; Penin F; Lohmann V; André P
    Trends Microbiol; 2011 Feb; 19(2):95-103. PubMed ID: 21146993
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 3.